Yahoo India Web Search

Search results

  1. Mar 18, 2024 · Women Inventors and Patent Holders. This section contains books on the history of women inventors and patent holders, and the individuals who discovered and invented extraordinary things for science. American Women Inventors by Carole Ann Camp. Call Number: T39 .C36 2004 FT MEADE. ISBN: 0766019136. Published/Created: 2004.

  2. 5 days ago · Chloroquine, the mainstay of modern antimalarial drugs, was first synthesized in Germany in 1934, and pyrimethamine was synthesized in the United States during World War II (1939–45) by a team that included future Nobel laureates George H. Hitchings and Gertrude B. Elion.

    • The Editors of Encyclopaedia Britannica
  3. 5 days ago · Robert Elion, Gertrude Elion's father. Courtesy of The Legacy of Gertrude Elion, Inventor of Medicines.

  4. 6 days ago · Gertrude B. Elion: New York City, United States "for their discoveries of important principles for drug treatment" 1988 George H. Hitchings: Hoquiam, Washington, U.S. "for their discoveries of important principles for drug treatment" 1986 Stanley Cohen: Brooklyn, New York, U.S. "for their discoveries of growth factors" 1986 Rita Levi-Montalcini

  5. 6 days ago · Of the 965 individual recipients of the Nobel Prize and the Nobel Memorial Prize in Economic Sciences between 1901 and 2023, [1] at least 214 have been Jews or people with at least one Jewish parent, representing 22% of all recipients.

  6. 6 days ago · Gertrude B. Elion (1918–1999), American pharmacologist known for using rational drug design for the discovery of new drugs; Daniel Giraud Elliot (1835–1915), American zoologist, founder of the American Ornithologist Union; Gladys Anderson Emerson (1903–1984), American historian and nutritionist, the first to isolate pure Vitamin E

  7. 5 days ago · Published compounds from ChEMBL version 32 are used to seek evidence for the occurrence of “natural selection” in drug discovery. Three measures of natural product (NP) character were applied, to compare time- and target-matched compounds reaching the clinic (clinical compounds in phase 1–3 development and approved drugs) with background compounds (reference compounds). Pseudo-NPs (PNPs), containing NP fragments combined in ways inaccessible by nature, are increasing over time ...